[Federal Register Volume 65, Number 186 (Monday, September 25, 2000)]
[Notices]
[Pages 57622-57623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24559]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 28,

[[Page 57623]]

2000, Noramco, Inc., 1400 Olympic Drive, Athens, Georgia 30601, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments, or objections may be addressed, in 
quintuplicate, to the Deputy Assistant Administrator, Office of 
Diversion Control, Drug Enforcement Administration, United States 
Department of Justice, Washington, D.C. 20537, Attention: DEA Federal 
Register Representative (CCR), and must be filed no later than November 
24, 2000.

    Dated: September 6, 2000.
John H. King,
Deputy Assisatnt Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-24559 Filed 9-22-00; 8:45 am]
BILLING CODE 4410-09-M